Imperial College London
Dr Ines Cebola

DrInesCebola

Faculty of Medicine, Department of Metabolism, Digestion and Reproduction

Senior Lecturer in Regulatory Genomics
 
 
 
//

Contact

 

i.dos-santos-cebola Website

 
 
//

Location

 

535ICTEM buildingHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Cebola:2019:10.1007/s11892-019-1230-6,
author = {Cebola, I},
doi = {10.1007/s11892-019-1230-6},
journal = {Current Diabetes Reports},
title = {Pancreatic Islet Transcriptional Enhancers and Diabetes},
url = {http://dx.doi.org/10.1007/s11892-019-1230-6},
volume = {19},
year = {2019}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - <jats:title>Abstract</jats:title><jats:sec><jats:title>Purpose of Review</jats:title><jats:p>Common genetic variants that associate with type 2 diabetes risk are markedly enriched in pancreatic islet transcriptional enhancers. This review discusses current advances in the annotation of islet enhancer variants and their target genes.</jats:p></jats:sec><jats:sec><jats:title>Recent Findings</jats:title><jats:p>Recent methodological advances now allow genetic and functional mapping of diabetes causal variants at unprecedented resolution. Mapping of enhancer-promoter interactions in human islets has provided a unique appreciation of the complexity of islet gene regulatory processes and enabled direct association of noncoding diabetes risk variants to their target genes.</jats:p></jats:sec><jats:sec><jats:title>Summary</jats:title><jats:p>The recently improved human islet enhancer annotations constitute a framework for the interpretation of diabetes genetic signals in the context of pancreatic islet gene regulation. In the future, integration of existing and yet to come regulatory maps with genetic fine-mapping efforts and in-depth functional characterization will foster the discovery of novel diabetes molecular risk mechanisms.</jats:p></jats:sec>
AU  - Cebola,I
DO  - 10.1007/s11892-019-1230-6
PY  - 2019///
SN  - 1534-4827
TI  - Pancreatic Islet Transcriptional Enhancers and Diabetes
T2  - Current Diabetes Reports
UR  - http://dx.doi.org/10.1007/s11892-019-1230-6
UR  - http://hdl.handle.net/10044/1/72682
VL  - 19
ER  -
Download